Signature BioScience Acquires Cambridge Discovery Chemistry from Millennium Pharmaceuticals | GenomeWeb

NEW YORK, July 16 - Signature BioScience has acquired Cambridge Discovery Chemistry (CDC) from Millennium Pharmaceuticals, Signature BioScience said Monday. Financial details were not disclosed.

Millennium had acquired CDC, based in Richmond, Calif., as part of its acquisition of UK-based Cambridge Discovery Chemistry Limited, the parent company of CDC, in July 2000. Millennium will continue to operate Cambridge Discovery Chemistry Limited as a wholly-owned subsidiary. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.